NRx Pharmaceuticals Valuation
| NRXPW Stock | USD 0.09 0 3.22% |
NRx Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of NRx Pharmaceuticals from analyzing the firm fundamentals such as Number Of Shares Shorted of 1.23 K, return on equity of -6.83, and Net Income of (25.13 M) as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that NRx Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of NRx Pharmaceuticals is based on 3 months time horizon. Increasing NRx Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NRx stock is determined by what a typical buyer is willing to pay for full or partial control of NRx Pharmaceuticals. Since NRx Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NRx Stock. However, NRx Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0901 | Real 0.0865 | Hype 0.09 | Naive 0.058 |
The intrinsic value of NRx Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence NRx Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of NRx Pharmaceuticals helps investors to forecast how NRx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NRx Pharmaceuticals more accurately as focusing exclusively on NRx Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use NRx Pharmaceuticals' intrinsic value based on its ongoing forecasts of NRx Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against NRx Pharmaceuticals' closest peers.
NRx Pharmaceuticals Cash |
|
NRx Valuation Trend
Analysing the historical paterns of NRx Pharmaceuticals' enterprise value and its market capitalization is a good way to estimate and gauge the value of NRx Pharmaceuticals over time and is usually enough for investors to make rational market timing decisions.
NRx Pharmaceuticals Total Value Analysis
NRx Pharmaceuticals is now projected to have takeover price of 0 with market capitalization of 714.61 M, debt of 6.58 M, and cash on hands of 24.55 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the NRx Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 714.61 M | 6.58 M | 24.55 M |
NRx Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of NRx is to check how much profit was generated for every dollar of assets it reports. NRx Pharmaceuticals secures a negative usage of assets of -2.25 %, losing $0.0225 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of NRx Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.NRx Pharmaceuticals Profitability Analysis
Net Loss for the year was (25.13 M) with profit before overhead, payroll, taxes, and interest of 0.About NRx Pharmaceuticals Valuation
Our relative valuation model uses a comparative analysis of NRx Pharmaceuticals. We calculate exposure to NRx Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NRx Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -5.8 K | -6 K |
NRx Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as NRx Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 10.5 M |
NRx Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of NRx Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value NRx we look at many different elements of the entity such as NRx's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as NRx Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use NRx Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes NRx Pharmaceuticals' worth.Additional Tools for NRx Stock Analysis
When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.